Dr. Allison Hsia, PhD is a Lead Clinical Scientist in Product Development Oncology & Hematology at Genentech, Inc., a member of the Roche group. She is the clinical scientist for two early-phase clinical trials, CROSSWALK-c (BO42451) and CROSSWALK-a (BO42452), that investigate complement inhibition in the treatment and prevention of pain crises in sickle cell disease.
She earned her Ph.D. in Biomedical Engineering from the University of California, Davis, where her research examined bone spur formation in a murine model of post-traumatic osteoarthritis. She currently resides in Tucson, Arizona with her husband and cat.
